Size exclusion chromatography (SEC) is the gold standard for separating protein aggregates from their monomers and has been widely used in the development and production of biopharmaceuticals. CD Formulation integrates cutting-edge SEC technology into our protein characterization technology platform to provide reliable analytical support for all stages of the development and production of your protein/peptide drugs, including formulation development, process development, drug release testing, and stability testing.
SEC, also known as gel filtration chromatography (GFC) or gel permeation chromatography (GPC), is one of the most effective methods for separating and purifying different proteins based on their molecular size (actually the Stokes radius of the particle). This technique has the advantages of simple operation, rapid separation, and no effect on biological activity, and is widely used in the separation and purification of proteins or peptides. Unlike other types of chromatography, such as ion exchange chromatography (IEX) or affinity chromatography (AC), SEC doesn't require a binding reaction between the sample components and the chromatographic medium for separation, so the sample buffer composition does not directly affect the separation. In addition, the buffer, temperature, pH, and other conditions can be changed according to different types of samples or further purification requirements. SEC can be performed directly before or after other chromatography methods.
In SEC analysis, samples are usually injected into a chromatographic column that is continuously flushed with mobile phase. Since the chromatographic column itself contains tiny porous beads, these beads are composed of dextran, agarose, silica or polyacrylamide (stationary phase). During the elution process, proteins with large molecular weights first flow out along the gaps between the gel particles, while proteins with small molecular weights can enter the gel mesh, causing flow blockage and slow outflow. Therefore, larger molecules elute faster than smaller molecules. In other words, the smaller the molecule, the longer the retention time.
Fig. 1 Principle of size exclusion chromatography (SEC). (Du M, et al., 2022)
Thanks to decades of experience supporting protein/peptide biopharmaceutical development and manufacturing using SEC technology, our team of highly qualified experts offers a range of SEC-related services to accelerate the implementation and success of your project.
Our experienced team of experts has completed hundreds of SEC separation and purification projects for protein and peptide, supporting all stages of your protein/peptide drug development and manufacturing - from early studies to downstream process monitoring and GMP batch release testing.
Utilizing cutting-edge SEC technology, we support the following protein/peptide development and characterization plans, including but not limited to:
SEC provides information about the size and shape of a protein and can be used to estimate its molecular weight. We determine the molecular weight of a sample by comparing the elution volume of a protein of unknown size to the elution volume of a standard protein of known molecular weight.
SEC is the method of choice for detecting and quantifying mAb aggregates, and we use SEC to distinguish between monomeric and oligomeric forms of a protein, as well as to identify any possible aggregates.
Protein conformational changes can affect elution behavior in SEC. By comparing SEC curves under different conditions (e.g., pH, temperature, ligand binding), we can infer structural changes in the protein.
SEC can be used to assess protein stability by monitoring the aggregation state of a protein over time or under various stress conditions (e.g., temperature, pH, or the presence of denaturants). Changes in the elution profile may indicate protein degradation or aggregation, helping to assess the stability of the formulation.
SEC can effectively separate proteins from smaller contaminants such as salts, nucleotides, and small molecules. Our scientists assess the purity of protein samples by analyzing elution profiles. A single sharp peak generally indicates high purity, while multiple peaks may indicate contamination or the presence of aggregates.
Our analytical laboratory is equipped with two SEC techniques, HPLC-SEC and UPLC-SEC, to support the separation and purification of protein drugs, including size determination, quantitative analysis, and molecular weight determination of fragments, monomers, and aggregates. The following detectors are used to detect various molecular species:
A mature, stable, and widely used technique for the size determination, quantitative analysis, and molecular weight determination of fragments, monomers, and aggregates. The size range of HP-SEC is determined by the pore size of the column and the method settings (e.g. mobile phase, flow setting, and column dimensions).
This technique can be used in all stages of biopharmaceutical development, as well as batch release testing. However, HP-SEC is the preferred choice, if increased sample throughput or better resolution is not required.
Published Data
Technology: SEC-nES GEMMA
Journal: Electrophoresis.
IF: 2.744
Published: 2021
Results:
The authors describe a novel online coupling of size exclusion chromatography (SEC) with gas phase electrophoresis. A panel of standard proteins of different molecular weights, including hemoglobin (~30 kDa - native dimer), ovalbumin (~44 kDa), and IgG (~147 kDa) and thyroglobulin (~660 kDa - native dimer) were selected as model proteins for validation. The SEC eluate was separated directly after the SEC column to monitor protein elution by gas phase electrophoresis and under a conventional UV/Vis detector. The results show that this approach can successfully separate analyte multimers already present in the liquid phase as well as remove non-volatile buffer components online prior to SEC-nES GEMMA analysis, allowing the detection and characterization of protein aggregates or non-covalently bound proteins in large-scale pharmaceutical production.
Fig. 2 Schematic drawing of the SEC–MacroIMS concept. (Weiss VU, et al., 2021)
CD Formulation aims to provide a powerful analytical tool for the separation, purification, and characterization of proteins and peptides. Please feel free to contact us if you are interested in our services. Learn how our SEC technology can support the smooth implementation of your protein/peptide biopharmaceutical program.
References